This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Kin-Kai Hwang: Pharmaceutical Patent Inventor
Introduction
Kin-Kai Hwang is an inventor associated with Overland Park, Kansas, and Aventis Pharmaceuticals Inc. His patent work addresses the bioavailability of antihistamine medications.
Latest Patents
Hwang is credited with 1 patent, titled “Method of Enhancing Bioavailability of Fexofenadine and Its Derivatives.” The invention describes co-administering a piperidinoalkanol antihistamine with a p-glycoprotein inhibitor to enhance the antihistamine’s bioavailability in a patient.
Career Highlights
Hwang’s documented patent contribution focuses on pharmaceutical treatment and the potential role of p-glycoprotein inhibition in improving the availability of antihistamine compounds.
Collaborations
Hwang’s listed coworkers include Gail H. Hurst and Dennis Giesing. His patent is associated with Aventis Pharmaceuticals Inc.
Conclusion
Kin-Kai Hwang’s patent reflects an effort to improve the bioavailability of fexofenadine and related antihistamines through a combination approach.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile